Paul Hodgkins

Summary

Affiliation: Shire BioChem Inc

Publications

  1. pmc A systematic review of global publication trends regarding long-term outcomes of ADHD
    Paul Hodgkins
    Shire Development Inc, Global Health Economics and Outcomes Research Wayne, PA, USA
    Front Psychiatry 2:84. 2011
  2. pmc Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners
    Suzanne McCarthy
    School of Pharmacy, University College Cork, Cork, Ireland
    Health Qual Life Outcomes 11:22. 2013
  3. pmc Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study
    Meryl Brod
    The BROD GROUP, Mill Valley, CA 94941, USA
    Health Qual Life Outcomes 10:47. 2012
  4. pmc Occupational issues of adults with ADHD
    Marios Adamou
    South West Yorkshire NHS Partnership Foundation Trust Manygates Clinic, Portobello Road, WF1 5PN, Wakefield, UK
    BMC Psychiatry 13:59. 2013
  5. pmc Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence
    Suzanne McCarthy
    School of Pharmacy, University College Cork, Cork, Ireland
    BMC Psychiatry 12:219. 2012
  6. pmc The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care
    Suzanne McCarthy
    School of Pharmacy, University College Cork, Cork, Ireland
    BMC Pediatr 12:78. 2012
  7. pmc Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study
    Lauren Matheson
    Department of Clinical Health care, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0FL, UK
    BMC Health Serv Res 13:184. 2013
  8. pmc Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    BMC Gastroenterol 13:23. 2013
  9. pmc Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
    Debanjali Mitra
    RTI Health Solutions, 3040 Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC, 27709 2194, USA
    BMC Gastroenterol 12:132. 2012
  10. pmc Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns
    Paul Hodgkins
    Shire Development, LLC, 725 Chesterbrook Boulevard, Wayne, PA 19087, USA
    Eur J Pediatr 172:895-906. 2013

Collaborators

Detail Information

Publications30

  1. pmc A systematic review of global publication trends regarding long-term outcomes of ADHD
    Paul Hodgkins
    Shire Development Inc, Global Health Economics and Outcomes Research Wayne, PA, USA
    Front Psychiatry 2:84. 2011
    ..This systematic review analysis of publication trends in ADHD LTOs reflects geographically based interests that change over time...
  2. pmc Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners
    Suzanne McCarthy
    School of Pharmacy, University College Cork, Cork, Ireland
    Health Qual Life Outcomes 11:22. 2013
    ....
  3. pmc Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study
    Meryl Brod
    The BROD GROUP, Mill Valley, CA 94941, USA
    Health Qual Life Outcomes 10:47. 2012
    ..The purpose of this study was to expand the understanding of the burden of illness experienced by adults with Attention Deficit-Hyperactivity Disorder (ADHD) living in different countries and treated through different health care systems...
  4. pmc Occupational issues of adults with ADHD
    Marios Adamou
    South West Yorkshire NHS Partnership Foundation Trust Manygates Clinic, Portobello Road, WF1 5PN, Wakefield, UK
    BMC Psychiatry 13:59. 2013
    ..ADHD is a common neurodevelopmental disorder that persists into adulthood. Its symptoms cause impairments in a number of social domains, one of which is employment. We wish to produce a consensus statement on how ADHD affects employment...
  5. pmc Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence
    Suzanne McCarthy
    School of Pharmacy, University College Cork, Cork, Ireland
    BMC Psychiatry 12:219. 2012
    ....
  6. pmc The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care
    Suzanne McCarthy
    School of Pharmacy, University College Cork, Cork, Ireland
    BMC Pediatr 12:78. 2012
    ..The aim of this study was to investigate the annual prevalence and incidence of pharmacologically treated ADHD in children, adolescents and adults in UK primary care...
  7. pmc Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study
    Lauren Matheson
    Department of Clinical Health care, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0FL, UK
    BMC Health Serv Res 13:184. 2013
    ....
  8. pmc Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    BMC Gastroenterol 13:23. 2013
    ..The objective of this study was to assess adherence and persistence to mesalamine treatments and their potential determinants in mild to moderate UC patients in a real-life setting in Quebec, Canada...
  9. pmc Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
    Debanjali Mitra
    RTI Health Solutions, 3040 Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC, 27709 2194, USA
    BMC Gastroenterol 12:132. 2012
    ..Observational cohort study to assess the association between adherence to oral 5-aminosalicylates (5-ASAs) and all-cause costs and health care utilization among patients with active ulcerative colitis (UC) in the United States...
  10. pmc Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns
    Paul Hodgkins
    Shire Development, LLC, 725 Chesterbrook Boulevard, Wayne, PA 19087, USA
    Eur J Pediatr 172:895-906. 2013
    ..Physicians' assessments of complete symptom control and physician satisfaction with treatment were low, indicating unmet needs with current ADHD management in Europe...
  11. doi request reprint Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis
    Paul Hodgkins
    Global Health Economics and Outcomes Research, Shire Development LLC, Wayne, Pennsylvania 19087, USA
    Inflamm Bowel Dis 19:386-96. 2013
    ..The current study examined the burden of disease and the impact of daily multimatrix (MMX®) mesalamine treatment on HRQoL for patients with active or quiescent mild-to-moderate UC...
  12. doi request reprint Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments
    Paul Hodgkins
    Global Health Economics and Outcomes Research, Shire Development, LLC, 725 Chesterbrook Boulevard, Wayne, PA 19087, USA
    Expert Rev Neurother 13:425-33. 2013
    ....
  13. pmc A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment
    Monica Shaw
    Clinical Development and Medical Affairs, Shire Pharmaceuticals, Ltd, Basingstoke, UK
    BMC Med 10:99. 2012
    ....
  14. pmc Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
    Paul Hodgkins
    Shire Pharmaceuticals, Wayne, PA 19087, USA
    Eur Child Adolesc Psychiatry 21:477-92. 2012
    ....
  15. doi request reprint Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment
    Paul Hodgkins
    Global Health Economics Outcomes Research, Shire Pharmaceuticals, Wayne, PA, USA
    Patient 5:33-44. 2012
    ..Patients with ulcerative colitis (UC) frequently require long-term therapy to prevent relapse. Treatments such as 5-aminosalicylic acid (5-ASA [mesalazine]) are efficacious and well tolerated, but adherence to treatment is often poor...
  16. pmc Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
    Oscar G Bukstein
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Child Adolesc Psychiatry Ment Health 3:39. 2009
    ....
  17. doi request reprint Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population
    Paul Hodgkins
    Global Health Economics and Outcomes Research, Shire Development Inc, Wayne, PA 19087, USA
    Curr Med Res Opin 27:53-62. 2011
    ..Describe treatment patterns, resource use, and predictors of methylphenidate (MPH) switch among children (6-12 years), adolescents (13-17 years), and adults (≥ 18 years) with attention-deficit/hyperactivity disorder (ADHD)...
  18. doi request reprint Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands
    Paul Hodgkins
    Global Health Economics and Outcomes Research, Shire Development Inc, Wayne, Pennsylvania 19087 5637, USA
    Clin Ther 33:188-203. 2011
    ....
  19. ncbi request reprint Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications
    Juliana Setyawan
    Shire Development LLC, Wayne, PA, USA
    J Med Econ 16:1275-89. 2013
    ..To compare treatment persistence in attention-deficit/hyperactivity disorder (ADHD) of patients initiated on lisdexamfetamine (LDX) vs other ADHD medications...
  20. pmc Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology
    Vanja Sikirica
    Global Health Economics and Outcomes Research, Shire Development LLC, 725 Chesterbrook Boulevard, Wayne, PA, 19087, USA
    CNS Drugs 27:943-53. 2013
    ....
  21. doi request reprint Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults
    Juliana Setyawan
    Shire Development, LLC, Wayne, PA, USA
    J Med Econ 16:1203-15. 2013
    ....
  22. doi request reprint Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity
    M Haim Erder
    Shire Development LLC, Wayne, PA, USA
    J Med Econ 15:1078-87. 2012
    ..An example application is based on two treatments for attention deficit hyperactivity disorder (ADHD): osmotic-release oral system methylphenidate (OROS-MPH) and lisdexamfetamine dimesylate (LDX)...
  23. doi request reprint Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison
    M Haim Erder
    Shire Development LLC, Wayne, PA 19087, USA
    Appl Health Econ Health Policy 10:381-95. 2012
    ..ATX has been on the market since 2002 while GXR was recently approved in 2009. To date, there is no comparative effectiveness or cost-effectiveness study comparing the two drugs...
  24. ncbi request reprint Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics
    Vanja Sikirica
    Global Health Economics and Outcomes Research, Shire Development LLC, 725 Chesterbrook Blvd, Wayne, PA 19087, USA
    J Manag Care Pharm 18:676-89. 2012
    ..The treatment patterns, resource utilization, and costs associated with AAPs relative to non-antipsychotic medications have not been evaluated for children with ADHD. ..
  25. doi request reprint Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis
    Juliana Setyawan
    Shire Development LLC, Wayne, PA, USA
    J Med Econ 16:962-75. 2013
    ..To assess treatment adherence in attention deficit/hyperactivity disorder (ADHD) patients initiated on Lisdexamfetamine (LDX) vs other FDA-approved stimulants and non-stimulant medications...
  26. doi request reprint Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands
    Rahul Sasane
    Global Health Economics and Outcomes Research, Shire Pharmaceuticals, Wayne, PA 19087, USA
    Curr Med Res Opin 26:2565-74. 2010
    ....
  27. doi request reprint The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?
    Paul Hodgkins
    Shire Pharmaceuticals, Wayne, PA, USA
    CNS Drugs 26:245-68. 2012
    ....
  28. pmc Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorder
    Vanja Sikirica
    Global Health Economics Outcomes Research and Epidemiology, SHIRE, 725 Chesterbrook Boulevard, Wayne, PA, 19087, USA
    Drugs R D 13:271-80. 2013
    ....
  29. pmc Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents
    Vanja Sikirica
    Global Health Economics and Outcomes Research, Shire Development LLC, 725 Chesterbrook Boulevard, Wayne, PA 19087, USA
    Pharmacoeconomics 30:e1-15. 2012
    ..However, approximately 30% of children with ADHD do not have an optimal response to a single stimulant and may require adjunctive therapy...
  30. doi request reprint Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis
    Keith Bodger
    aGastroenterology Department, Digestive Diseases Centre, Aintree University Hospital, Institute of Translational Medicine, University of Liverpool, Liverpool bCovance, Leeds, UK cShire, Wayne, Pennsylvania dCovance, Gaithersburg, Maryland, USA
    Eur J Gastroenterol Hepatol 26:213-21. 2014
    ..This study identifies and assesses medical resource utilization (MRU) and associated direct costs in mild and moderate UC patients in the UK...